🕒 Thursday 22 May 2025 Thu, 22 May 2025
80 Articles
NFM Fast-Tracks Copper Production with Mt Kelly Processing Alliance
New Frontier Minerals advances its NWQ Copper Project by securing bulk sample processing at Austral Resources’ Mt Kelly plant, accelerating its path to copper production in Queensland’s Mt Isa Copper Belt.
22 May
Maxwell Dee
AACo FY25 Profit Climbs 14% as Volume Growth Offsets Price Pressures
Australian Agricultural Company Limited (AACo) reported a 14% rise in operating profit to $58.4 million for FY25, driven by increased sales volumes and disciplined cost control despite challenging market conditions. The company also marked a significant reduction in statutory loss, signaling improved financial resilience.
22 May
Ada Torres
AACo Boosts FY25 Profit and Expands Premium Brands Amid Market Challenges
Australian Agricultural Company Limited (AACo) reported a robust FY25 operating profit of $58.4 million, driven by increased meat and cattle sales volumes and strategic brand growth despite inflationary pressures.
22 May
Ada Torres
AACo Posts 164% Surge in Operating Profit Amid Rising Sales
Australian Agricultural Company Limited (AACo) has reported a robust turnaround in its FY25 results, with significant gains in revenue and profitability driven by higher sales volumes and improved operational efficiency.
22 May
Ada Torres
Oceania Healthcare Boosts EBITDA 4.1% and Unveils Bold Five-Year Strategy
Oceania Healthcare reported a 4.1% rise in underlying EBITDA for FY25, driven by strong sales and operational improvements, while launching a new strategic plan focused on growth and efficiency.
22 May
Ada Torres
AFT Pharmaceuticals Eyes NZ$300M Revenue with Global Expansion Momentum
AFT Pharmaceuticals reported a 6% revenue increase to NZ$208 million in FY25, driven by strong ANZ growth and expanding international presence. The company targets NZ$300 million revenue by FY27 amid ongoing R&D and new product launches.
22 May
Ada Torres
AFT Pharmaceuticals Hits NZD 208M Revenue, Eyes NZD 300M by FY27
AFT Pharmaceuticals has reported record revenue of NZD 208 million for FY25, driven by strong Australasian sales and a recovery in Asia and international markets. The company is targeting NZD 300 million in revenue by FY27, supported by an expanded R&D pipeline and ongoing geographic diversification.
22 May
Victor Sage
AFT Pharmaceuticals Grows Revenue 6% Despite 23% Profit Slide
AFT Pharmaceuticals reported a 6% increase in revenue to NZ$208 million for the year ending March 2025, but net profit fell 23%, prompting a modest final dividend declaration.
22 May
Ada Torres